arrow
C

Claudio Solaro

crrf “mons. luigi novarese”
H指数:49
被引数:7,754

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Advance care planning in multiple sclerosis (ConCure-SM): A multicenter single-arm pilot and feasibility study

多发性硬化中的预先护理计划(ConCure-SM):一项多中心单臂试点与可行性研究

2025-10-070
PRE
Investigating the orthotic effect of a passive gravity-compensated exoskeletal device on upper-limb function in people with multiple sclerosis: a pilot cross-sectional study

调查一种被动重力补偿外骨骼装置对多发性硬化患者上肢功能的矫形作用:一项试点横断面研究

2025-08-270
OAAI
Effects of high-intensity multimodal functional training on motor and cognitive functions in people with multiple sclerosis: A study protocol of a pilot randomized controlled trial

高强度多模式功能性训练对多发性硬化患者运动和认知功能的影响:一项小规模随机对照试验的研究方案

2025-08-060
OA
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data

基于真实世界常规临床数据的个性化联邦学习在预测多发性硬化致残进展中的应用

2025-07-240
OAAI
Explainable time-to-progression predictions in multiple sclerosis

多发性硬化症可解释的进展时间预测

2025-05-010
PRE
Effectiveness, safety, and impact on multiple sclerosis course of anti-CGRP monoclonal antibodies
2025-02-011
PRE
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study

那他珠单抗治疗继发性进行性多发性硬化的长期疗效: 一项倾向匹配研究

2024-07-011
OAAI
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial

多种疾病改善疗法在复发缓解型多发性硬化症中的有效性: 模拟多臂随机试验的因果推断

2023-07-062
PRE
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

继发性进行性多发性硬化症的风险由地理位置决定,但可以改变

BRAIN
IF11.7
2023-06-275
OAAI
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs

用高效dmt治疗的多发性硬化症患者接受三种mRNA疫苗剂量后的症状性新型冠状病毒肺炎过程和结局

2023-05-117
OA
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

早期非残疾复发是复发缓解型多发性硬化症患者残疾积累的重要预测因素

2023-02-279
OAAI
Comparative effectiveness in multiple sclerosis: A methodological comparison

多发性硬化症的比较效果: 方法学比较

2023-02-193
PRE